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Abstract	  
Nicotine-­‐induced	  escalation	  of	  ethanol	  intake-­‐	  an	  effect	  mediated	  by	  the	  
vagus	  nerve?	  
	  
There is a clear connection between alcohol abuse and smoking. Previous studies 
show that 83% of those with alcohol abuse also smoke and that alcoholism is 10 times 
more common in smokers than in non-smokers. This clinical observation also finds 
support in pre-clinical animal studies where nicotine treatment has shown to increase 
ethanol intake in rats. Current research shows that central nicotinic acetylcholine 
receptors (nAChR) play a vital role in the dopamine releasing effects of ethanol. 
However, other studies have demonstrated that blockade of peripheral ganglionic 
nAChR invokes some kind of adaptations, which in turn escalates ethanol intake. We 
have reason to believe that both peripheral and central nAChR are involved in ethanol 
consumption. Since the vagus nerve receives input via nAChRs and is a big 
contributor to the autonomic nervous system, our hypothesis is that this nerve 
mediates the nicotine-induced escalation of ethanol intake. Thus this present study 
focused on designing a method that allowed us to surgically ligate certain branches of 
the vagus nerve in the rat thus removing the peripheral nAChR influence of ethanol 
intake. If we manage to establish a successful method we will later be able to let 
vagotomized rats undergo an ethanol-consumption study where we can evaluate if the 
abolished influence of the vagus nerve changes nicotine-induced escalation of ethanol 
intake.  
A total of 16 animals across 4 trials were operated on during the course of this study. 
6 animals were judged to have a successful vagotomy, resulting in a 40% success rate 
for the surgical procedure. However, we faced great challenges with stabilizing the 
animals in the post-operative phase due to persisting weight loss, but were finally 
successful in stabilizing the weight in trial 4 with a liquid diet. All in all, we managed 
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to achieve a successful gastric vagotomy with a stable post-operative weight gain in 
only 1 animal of the 16 operated. Conclusively, more surgical practice is needed 
before achieving an optimal method. However, we believe that with practice, a higher 
success rate of vagotomy can be achieved and along with a post-operative diet based 
on liquid diet we will have vagotomized animals stable enough to undergo a voluntary 
ethanol intake paradigm. 
Key	  words:	  Ethanol	  intake,	  nicotine,	  vagus	  nerve,	  vagotomy.	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Introduction	  
	  
According to the 2014 WHO Global status report on alcohol and health 
approximately 5.9%, or 3.3 million, of all global deaths were caused by harmful use 
of alcohol. In 2010 alcohol was the third largest risk factor of global disease and 
burden, resulting in 139 million disability adjusted life years (DALY) worldwide [1].  
Furthermore, the same study also stated that tobacco smoking was the second largest 
risk factor of global disease. Together tobacco and alcohol use stood for 11.8% of the 
global disease burden, meaning that more than one in ten people had a disease caused 
by either tobacco or alcohol. This exemplifies the huge importance of finding 
strategies to prevent and treat addiction to these substances, thus research in addiction 
biology is a vital part of decreasing the global disease burden.  
 
One of the biggest scientific achievements in addiction biology has been the 
discovery of the role of dopamine in the brain reward system, which is a key structure 
for development and maintenance of dependence to drugs [2]. The brain reward 
system is a circuitry between several areas in the brain, including the ventral 
tegmental area (VTA), nucleus accumbens (nAc), prefrontal cortex (PFC), basal 
ganglia, dorsal striatum (DS), amygdala (AMG) and hippocampus (HPC) [3]. It has 
been shown that all these areas play a different role in drug dependence but that the 
pathway between VTA and nAc, also known as the mesocorticolimbic dopamine 
system, is the most central part of the reward system [4]. The VTA contains a cluster 
of dopaminergic neurons with efferent projections to the nAc. Activation of these 
dopaminergic cells can cause and outflow of dopamine in the nAc. This extracellular 
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increase of dopamine in the nAc mediates the rewarding effect of different stimuli. 
These include natural stimuli such as food and sex as well as drugs. The increased 
dopamine levels creates a sense of reward motivating us to repeatedly exposing 
ourselves to such stimuli, when this gets out of control a dependence to the stimuli is 
evolved [3].  Previous studies show that drugs of abuse, such as ethanol, nicotine, 
cocaine, amphetamine and opiates, all share the common ability to activate the 
mesocorticolimbic dopamine system and that an increase in dopamine levels in this 
area maintains the dependence on drugs [5]. The exact mechanism for how some of 
these different drugs activate the dopamine neurons is still subject for investigation. 
There seems to be both a direct and indirect modulation of these dopaminergic 
neurons. For example psychostimulants such as cocaine and amphetamine exert their 
dopamine increasing effect in the nAc by manipulating monoamine reuptake 
transporters in presynaptic terminals in the nAc. These transporters have the function 
to pump back extracellular neurotransmitters such as dopamine into the presynaptic 
terminals. Cocaine binds to these transporters inhibiting their function, resulting in 
greater levels of extracellular dopamine. Amphetamine both inhibits the reuptake 
transporters and also reverses their transport function creating an outflow of dopamine 
from the presynaptic terminal, resulting in greater extracellular levels of dopamine 
[3]. Opioids seem to exert their reinforcing effect through µ-receptors. Stimulation of 
µ-receptors increases firing of dopaminergic neurons in the VTA resulting in 
dopamine release in the nAc [6]. Also, it has been shown that opioids act on µ-
receptors on GABA interneurons resulting in a disinhibition of dopaminergic neurons. 
Nicotine also stimulates dopamine release by increasing firing of dopaminergic 
neurons. Nicotine acts by stimulating nicotinic acetylcholine receptors (nAChR), 
which can be found on dopaminergic neurons in the VTA [6]. Nicotinic receptors can 
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also be found on GABA interneurons as well as glutamatergic neurons. Nicotine acts 
on these and subsequently disinhibits respectively increases activity of dopaminergic 
neurons [6]. When it comes to ethanol the mechanism for dopamine release is still not 
clearly understood and several different hypotheses have been forwarded. One of 
these hypotheses comes from Gothenburg, where the Addiction Biology Unit has 
suggested that ethanol increases dopamine in the nAc by activating a network of 
neurons. In a long series of studies they have found that ethanol primarily, directly or 
indirectly, act on glycine receptors in the nAc, which in turn disinhibits GABAergic 
neurons projecting to the VTA. This produces a decrease of inhibitory GABAergic 
tone in the VTA allowing increased release of acetylcholine in the dopaminergic cell 
body region. This increase of extracellular acetylcholine activates nAChR located on 
dopaminergic neurons projecting to the nAc producing an increased dopamine release 
in the nAc [7].    
 
Knowing that dopamine release in the mesocorticolimbic dopamine system seems to 
be the common denominator for all drugs of abuse to produce brain reward gives a 
clearer understanding about why people with addiction often are prone to abuse 
multiple substances. An excellent example of this phenomenon is seen in the co-abuse 
of tobacco and alcohol. The fact that there are an elevated number of smokers in a 
population consisting of people with alcohol abuse has been known for a long time 
[8]. A case-control study comparing smoking in alcoholic and non-alcoholic 
individuals showed that 83% of those with alcohol abuse also smoked, compared to 
34% of those in the control group. The same study also stated that alcoholism was 10 
times more common in smokers than in non-smokers and that only 7% of the 
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alcoholic population was able to quit smoking compared to 49% of the non-alcoholic 
population [9].  
 
Thus it is obvious that there is a clear connection between smoking and alcohol 
consumption. Now the question becomes why? Many would argue that environmental 
factors such as socioeconomic status play a big role. Also a genetic predisposition for 
developing dependence to drugs of abuse may be a part of the explanation. While 
these factors may well explain a positive correlation between tobacco and alcohol, it 
would also suggest that this correlation exists between all addictive drugs, which is 
not the case. Rather, it has been shown that there are physiological/pharmacological 
mechanisms that contribute to the co-abuse of alcohol and tobacco. As mentioned 
above, it has been shown that nAChR play an important role in the dopamine 
releasing mechanism of ethanol. As previously explained activation of nAChR on 
dopaminergic neurons in the VTA produce dopamine release in the nAc following 
both ethanol and nicotine administration [10]. Since it was shown that nAChRs play 
an important role in the dopamine elevating properties of ethanol it was hypothesized 
that these receptors also participate in ethanol consumption. Knowing that ethanol -
induced dopamine release decreases by blocking central nicotinic receptors it is only 
logical to think that a stimulation of these receptors should result in an opposite effect 
[11]. If so, this could be a possible physiological explanation for the correlation 
between smoking and alcohol consumption as mentioned earlier.  
 
To gain more knowledge about this mechanism studies have been carried out on rats 
in controlled conditions where the influences of other factors are minimal. In these 
studies the animals were given a free choice between ethanol and water during a 
	   9	  
period of time prior to being exposed to subchronic nicotine treatment. When 
reintroduced to the free choice between ethanol and water it was shown that animals 
that had been pretreated with nicotine significantly increased their ethanol intake. 
Nicotine treated rats were also more likely to consume ethanol than water, indicating 
an increased preference towards ethanol. This nicotine-induced increase of ethanol 
consumption could be reversed by pre-treatment with mecamylamine, a nAChR 
antagonist [12].  Using microdialysis in freely moving animals, it was also shown that 
the release of dopamine in the limbic forebrain of rats exposed to acute nicotine or 
ethanol increased if they had been subchronically pre-treated with nicotine [12]. Thus 
nicotine treatment seems to facilitate the effects of ethanol, resulting in a greater 
ethanol intake in an animal exposed to nicotine. An interesting observation in this 
study was also that these effects lasted several weeks after nicotine treatment was 
seized. This indicates that subchronic nicotine treatment induces some kind of 
neuroplasticity in the brain [12].  In previous studies [13,14] it has been suggested 
that chronic exposure to nicotine may upregulate central nAChR, resulting in an 
increased dopaminergic release. Another explanation might be that nicotine sensitizes 
the mesocorticolimbic dopamine system, which would result in a greater release of 
dopamine when exposed to nicotine/ethanol. Thus, it was concluded that (1) blocking 
central nAChR prevents ethanol from increasing nAc dopamine and (2) acute 
blockade of nAChRs results in a decreased intake of ethanol.  
 
As mentioned above previous microdialysis studies show that it is the central nAChR 
that mediates the dopamine releasing effects of ethanol and not the peripheral 
receptors. When it comes to ethanol intake though, an interesting observation was 
made in a study from Gothenburg [15]. In this study rats in a voluntary ethanol 
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paradigm were subchronically treated with nicotine, mecamylamine (a nAChR 
antagonist that can pass the blood-brain-barrier), hexamethonium (a nAChR 
antagonist that can´t pass the blood-brain-barrier) or vehicle during 15 days. After 
treatment the rats were reintroduced to voluntary ethanol consumption. An increase in 
ethanol intake and preference was unexpectedly seen in all animals except the vehicle 
group. Treatment with nicotine + mecamylamine or nicotine + hexamethonium did 
not counteract the nicotine-induced escalation of ethanol intake, on the contrary 
treatment with nicotine + hexamethonium seemed to increase the ethanol intake more 
than nicotine alone.  
 
 
 
 
 
 
 
Fig.1 Shows the effect on ethanol intake and preference after administration of nicotine, mecamylamine and 
hexamethonium. 
Source: Ericson, Jörgen A. Engel, Bo Söderpalm. 1999. Peripheral involvement in nicotine-induced enhancement 
of ethanol intake. Alcohol, volume 21.  
 
The common denominator in all of these substances (nicotine, mecylamine and 
hexamethonium) is the fact that they all induce a blockade of peripheral nAChR. 
Nicotine, although known as an agonist at the nAChR, does so by binding to the 
nAChR and after stimulation the bond between the nicotine molecule and the receptor 
remains for a period of time, causing a blockade, desensitization, of the nAChR. Thus 
it seems like it is the blockade of peripheral nAChR that causes a state where the 
animals increase their ethanol intake. This effect also remains after treatment has been 
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ceased, yet again indicating some kind of neuroplasticity in the brain, which given the 
results from this study seems to be caused by the peripheral blockade of nAChR.  
The same study also showed that treatment with peripheral anti-muscarinic drug 
significantly reduced the ethanol intake during the first 3 days in nicotine-pretreated 
animals. After 3 days this effect was gone, which can be explained by the rapid 
tolerance development known for anti-muscarinic drugs. Thus it may well be that 
peripheral blockade of nAChR causes an autonomic compensatory mechanism where 
increased peripheral autonomic activity stimulates the ethanol reinforcing effects of 
central nAChR rather than direct stimulation of central nAChR. This gives support to 
the fact that peripheral neurotransmission seems to be involved in the enhancement of 
ethanol intake [15].  
 
To summarize, it is hypothesized that central nAChR are involved as one of the steps 
of how ethanol induces dopamine release in the nAc. Studies show that by blocking 
central nAChR the dopamine releasing effect of ethanol can be prevented. In addition, 
acute antagonism of nAChRs decrease ethanol intake in rats.  Furthermore, it has been 
shown that subchronic treatment with nicotine increases ethanol intake in the rat, but 
interestingly this effect can’t be counteracted with simultaneous chronic 
administration of central or peripheral nAChR antagonists. On the contrary previous 
results suggest that subchronical blockade of peripheral nAChR rather increases 
ethanol intake and that this effect remains after cessation of the antagonist. Why this 
occurs is unclear. One theory is that perhaps a signal pathway exists between the 
peripheral nAChR and the brain reward system, where blockade of the peripheral 
receptors causes neuroplastic adaptations, which in turn increases the ethanol 
reinforcing effects. This communication between peripheral and possibly the 
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mesolimbic dopamine system may be mediated by increased autonomic activity since 
a blockade of muscarinic receptors has shown to decrease ethanol intake in the 
nicotine-pretreated rat. 
 
The aim is now to find out where this signal pathway lies in the body. In mammals 
nAChR are divided into two principal groups: muscle and neuronal type. In turn the 
neuronal type nAChR can be found in the central nervous system (CNS) and in 
autonomic ganglia (autonomic nervous system). The peripheral nAChR in the 
autonomic ganglia are the ones that are thought to play a role in the nicotine-induced 
increase of ethanol intake mentioned above, since they play a central role in 
autonomic neurotransmission [16]. The autonomic nervous system (ANS) is known to 
have both efferent and afferent function. In our case afferent function is of interest 
since we are looking for a pathway that mediates signals from the peripheral 
ganglionic nAChR to the brain reward system. As mentioned above this 
communication seems to be mediated by an increased autonomic activity. Given this 
information, hypothetically the vagus nerve may be a likely candidate for mediating 
these signals since it is known to play a substantial role in the ANS. The vagus nerve 
is the 10th cranial nerve (n.X) of the body and the main contributor to the 
parasympathetic system. The nerve extends from the medulla oblongata and proceeds 
through the thoracic cavity and the abdomen, giving out branches to several visceral 
organs such as the heart, lungs, liver, pancreas, spleen and the gastrointestinal canal. 
The vagus nerve exhibits both an efferent and afferent function, using acetylcholine as 
its main neurotransmitter. In the case of afferent signals, up to 80% of the vagal fibers 
in the abdomen are thought to be afferent [17], which makes this location interesting 
for our hypothesis. Involvement of the vagus nerve in ethanol consumption in the rat 
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is also supported by an older study that investigated the role of gastric branches of the 
vagus nerve on voluntary alcohol intake. This study found that ligation of the gastric 
vagus nerve decreased alcohol intake in the rat and hypothesized that this part of the 
nerve may relay information regarding alcohol consumption to the brain [18]. We 
believe that if we can ligate the afferent signal transmission in the gastric branches of 
the vagus nerve, we may abolish the increase of autonomic activity that is believed to 
mediate the communication between peripheral nAChR and the brain. This should 
then prevent the escalation of ethanol intake in rats exposed to subchronic nicotine. 
To test this hypothesis we first need to establish a method where we successfully can 
manipulate the vagus nerve. In humans, manipulation of the vagus nerve was a 
standard procedure during the 1980s when vagotomy was used for treatment of peptic 
ulcer. Although this procedure is now outdated following the introduction of 
Histamine H2 receptor-blockers, there are still a lot of material left from animal 
studies of that era describing the vagotomy procedure.  The purpose of this study was 
to use that material on operational guidelines and try to recreate a method to perform 
gastric vagotomy in the rat. 
 
Hypothesis	  and	  Aim	  	  
Our hypothesis is that peripheral ganglionic nAChR communicates with the brain 
reward system through vagal transmission. We believe that once the vagal 
transmission is abolished, nicotine treatment will no longer produce an increase of 
ethanol intake in the rat. 
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The aim of this present study was to develop a method that allows us to ligate the 
gastric branches of the vagus nerve in the rat. The goal was to have vagotomized rats 
stable enough to undergo a future ethanol-consumption study where we can evaluate 
if nicotine-treatment still produces an escalation of ethanol intake. 	  
Ethics	  	  
To carry out experimental studies on animals it is required to have an approved 
ethical application that applies with the laws of animal protection. The present study 
was approved by the Ethics Committee for Animal Experiments, Gothenburg, 
Sweden according to the ethical laws for animal studies.   
Method	  
 
	  
Animals	  	  
A total of 16 animals were used across 4 different trials. The animals consisted of 
male Wistar rats weighing approximately 200 g and were supplied by Taconic (Ejeby, 
Denmark). Upon arrival in the animal department, all four animals were housed in 
one cage (55 x 35 x 20 cm) at constant room temperature (22°C) and humidity (65%) 
for 2 weeks to adapt to the novel environment. After surgery the animals were put in 
individual single-cages. The animals were kept under artificial light ± dark conditions 
(light on at 9:00 P.M. and off at 9:00 A.M.) and had free access to rat and mouse 
standard feed (Beekay Feeds) and tap water prior to surgery. In trial 2-4 the animals 
were put on a special diet 3-5 days before surgery for adaptation purposes.  
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Practice	  period	  	  
In order to gain better understanding of the anatomical outlay in the abdomen of the 
rat, practice was undertaken in sacrificed rats from other ongoing trials in the lab 
before proceeding with live animals. A total of 8 rats served as subjects during this 
practice period. A simulation of the whole surgical procedure was performed, 
including attempts to identify the abdominal parts of the vagus nerve and its gastric 
branches. This made it possible for the operator to gain a clear visualization of the 
different steps in the procedure and a realistic appreciation of the location of the 
different abdominal organs. 
 
Anesthesia	  	  
The fundamentals of anesthesia were based on the method used for probe-operation 
for microdyalisis in the lab of Söderpalm and Ericson. Isoflurane (Forene 100%) was 
used as the anesthetic drug and given in inhalation form using a vaporizer. When 
using this method general anesthesia is induced by placing the animal in a chamber 
that contains a constant flow of isoflurane (flow 600ml/min, concentration 4%), 
during 5 minutes. The animal was then transferred to a facemask and the flow and 
concentration of isoflurane was decreased to 400ml/min at 3.6% to maintain the 
general anesthesia during the procedure.  
This method was used in trial 1 for the first animal, which did not survive the surgical 
procedure. It was believed that a probable cause for its death might have been a too 
heavy sedation. Since vagotomy is a longer procedure than the probe-insertion for 
microdyalisis it is probable that by keeping the flow and concentration of isoflurane at 
400ml/min at 3.6% during a longer period of time may cause respiratory distress or 
severe hypotension. We figured that maybe by gradually decreasing the flow rate and 
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concentration of isoflurane during the procedure could increase the chances of 
survival. This hypothesis was tested during surgery for the next animal in trial 1. 
Induction was performed in the same way as described above. After transferring the 
animal to the facemask the flow rate and concentration was decreased to 400ml/min at 
3.8%. Flow rate and concentration of isoflurane was then gradually decreased during 
different steps of the surgery. Using this method a schedule for anesthesia was 
established (see table 1) for all of the following procedures across the 4 experiments.  
 
Flow rate (ml/min) Concentration (%) Surgical step 
600 4 Induction 
400 3.8 Moving to face mask 
345 3.6 Performing vagotomy 
340 3.4 Closing 
Table 1. Schedule for anesthesia with Isoflurane (Forene 100%) 
 
Operation	  	  
The surgical procedure for selective gastric vagotomy was based on the method 
described by Smith and Jerome in 1981 [19]. After anesthesia the animal was placed 
on a heating pad on the operation table to prevent hypothermia during surgery.  The 
procedure began with a mid-line incision in the abdomen from the xyphhoid process 
down to the level of the umbilicus. The abdominal muscles were retracted with four 
clamps placed two on each side in order to gain exposure into the abdominal cavity. 
Wet sponges were used to move the liver laterally for better access to the ventricle. 
Care was taken to not harm the liver with any sharp objects. Wet sponges were also 
placed above any exposed parts of the intestines. With a hemostat the xyphoid process 
was bent cranially to make free way in to the ventricle. The ventricle was then pulled 
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outwards from the abdominal cavity with forceps and a 3-0 silk suture were placed in 
the major curvature. The ends of the sutures were then clamped with a hemostat and 
light traction of the ventricle was made possible by gently pulling the hemostat. This 
gave us better exposure of the esophagus as it entered the abdomen below the 
diaphragm. When reaching this stage of the operation a microscope was used to 
identify the fibers of the vagus nerve. There are two major vagal trunks located on the 
left (posterior) and the right (anterior) side of the esophagus just below the diaphragm 
(see fig 1). When following the anterior vagus nerve caudally one can identify the 
hepatic branch leaving to the liver. Below that level is the beginning of the right 
(anterior) gastric branch, which runs along the lesser curvature of the ventricle. The 
left gastric branch emerges at the level of the distal esophagogastric junction where 
the left vagus nerve divides into the coeliac and left gastric branch. The left gastric 
branch then runs posterior to the ventricle and can therefor be hard to identify (see fig 
1). One way to locate the left gastric branch is to rotate the ventricle slightly to the 
right. After identification of what was thought to be the right and left gastric branches 
dissection of these nerve fibers were made using micro-dissection forceps. The fibers 
were dissected until they no longer were seen in the area. Care was taken to not harm 
the wall of the esophagus and the ventricle. Any minor bleeding was stopped with 
moist gauzes and the area was flushed with saline in order to clear the field of any 
debris. After finishing dissection the suture in the major curvature of the ventricle was 
removed and the ventricle was placed back in its original position. The wet sponges 
were also removed and the liver placed back in place. The abdominal muscle layers 
were then closed with interrupted 4-0 vicryl sutures. The skin was closed with 
interrupted 4-0 ethilon sutures. After closing the wound Rimadyl (Caprofen, 5mg/kg) 
was injected subcutaneously to manage the post-operative pain. 
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In trial 4 a new surgical approach was taken. In these animals a lower mid-line 
incision was made in the abdomen. After retracting the abdominal muscles the small 
and large intestines were lifted out and placed extra abdominally and covered with 
plastic, which was kept moist with sterile water. This allowed us to navigate more 
freely in the abdominal cavity and approach the ventricle and lower esophagus from 
underneath. This resulted in less risk of damaging the liver or diaphragm compared to 
the method described above. The remaining part of the operation was carried out as 
described above and after dissection of the vagus nerve branches the intestines were 
put back into the abdominal cavity in a careful manner. Initially the wound was closed 
with sutures. In trial 4 we experienced for the first time a problem with animals 
chewing through their sutures. Therefore the wound was secured again with wound-
clips.  
Sham operation was carried out in the same exact manner, except no dissection of the 
nerve fibers were made.  
 
 
Fig 2. Shows a schematic picture of the abdominal branches of the vagus nerve. 
 Source:  Jerome and Smith. Gastric Vagotomy inhibits drinking after hypertonic saline. 
Physiology & Behaviour 1981 14th Sep, Vol 28. 	  	  
	   19	  
	  
Post-­‐operative	  care	  	  
After operation the rats were placed in single cages with access to food and water ad 
libtium. The animals as well as the bottles containing water and food were weighed 
after 4 p.m. everyday. The general state of the animals was closely observed and the 
wound was checked for infection or leakage. Rimadyl (5mg/kg) s.c was administrated 
daily the first 5 days for pain-management. The average follow-up time before 
termination for trial 1-3 was 10 days due to rapid weight loss and 21 days for trial 4.  
 
Diet	  	  
Different types of diets were used during the study in order to find an alternative that 
was best suited to prevent rapid weight loss in the animals. In trail 1 the main aim was 
to have animals surviving the surgical procedure. Therefore regular solid food, in the 
form of pellets (from Beekay Feeds), was given both before and after surgery. It was 
quickly observed that food intake decreased post-operatively in these rats. Thus in 
trial 2 the pellets were replaced with a more soluble type of gel food (DietGel 
Recovery from Clear H20, 120kcal/cup), which was thought to pass easier through 
the gastrointestinal canal. The weight loss was less rapid with the gel food but still not 
satisfactory. Therefore a liquid diet consisting of nutrition drinks (Resource 2.0 from 
NestleHealthScience, 2kcal/ml) was used for trial 3 and 4. Because it was obvious 
that the animals had a significantly lower food intake after surgery a nutrition drink 
with a high calorie content/ml (2kcal/ml) was chosen, with the aim to stabilize the 
post-operative weight. All animals had access to the chosen diet during 3-5 days 
before the day of operation. This was to let the animals adapt to the special diet. The 
animals were weighed every day during this period. After surgery, all animals had 
access to the chosen diet and tap water ad libitum.  
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Water was given in clear plastic bottles with ball-valve sprouts. The bottles were 
filled with fresh water every other day. The pellets were placed on the cage as it was 
during the acclimation period. Gel food was also administrated by being placed on the 
cage. A fresh batch of gel food was given everyday and the old batch was replaced, 
this was to prevent the food from hardening. Administration of gel food in cups 
placed inside the cage was tested, but this alternative was abandoned due to the fact 
that the animals chewed through the plastic cups. The liquid diet was administrated in 
clear plastic bottles with ball-valve sprouts. The bottles were filled with fresh liquid 
diet every day in order to prevent the dairy in the diet from going sour.  
The bottles with water and the liquid diet in trial 3-4, as well as the animals were 
weighed daily.  
	  	  
Verification	  	  
It is known that gastric vagotomy decreases motility and acid secretion in the 
ventricle. This leads to retention of solid food and distention of the ventricle in 
vagotomized animals [20]. Completeness of gastric vagotomy can therefore be 
verified by measuring ventricle to total body weight ratio after 12h food deprivation. 
This ratio needs to be >0.020 for successful verification [20]. The animals were 
switched to solid pellet food at the end of the study and then deprived of food for 12h 
before being terminated. The animals were weighed and then heavily anaesthetized 
with isoflurane during 5 minutes before termination was performed by decapitation. 
After termination the abdominal sutures were removed and the wound cut open. The 
ventricle was located and ligated at the esophagogastric junction and the proximal 
duodenum before taken out and being weighed. After weighing the ventricle it was 
cut open to check the consistency of the content. Solid content was another sign of 
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successful vagotomy due to the lack of acid breaking down the food. The intestines 
were also checked thoroughly for signs of perforation.  The ratio was calculated by 
dividing the weight of the ventricle by the total bodyweight of the animal. 
 
                           
Results	  
 
In the present study 16 rats were used in order to develop a successful method ligating 
the vagus nerve. The animals were grouped equally (4 animals/trial) into four 
different trials (as described below) where each trial was followed by an evaluation. 
 
Trial	  1	  	  
A total number of 4 animals were operated on in trial 1. Three of the animals survived 
surgery, while one animal died on the operating table. It is believed that the cause of 
death was an overdose of anesthesia. Animals in trial 1 were fed a solid diet 
consisting of pellets. Post-surgical weight loss was seen in all of the surviving 
animals, with rat 3 having the most rapid weight loss of 8.33 g/day and a total loss of 
14.5% of the bodyweight in 6 days. Overall, animals in trial 1 experienced the most 
Fig 3. Shows a picture comparing the size of two ventricles during verification. The 
top ventricle belongs to a successfully vagotomized rat and the bottom ventricle 
belongs to a rat judged to have unsuccessful vagotomy.  
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rapid weight loss compared to the other trials. Due to this fact all animals had to be 
terminated within 8 days after surgery in accordance to ethical guidelines. After 
termination rat 2 and 4 were judged to have successful vagotomies (see method 
section for details regarding verification method). Except weight loss, no other post-
operative complications, such as infections, were observed. 
	  
Day	   Rat	  2	  (g)	   Rat	  3	  (g)	   Rat	  4	  (g)	  
1	   350	   365	   357	  
2	   342	   385	   356	  
3	   330	   346	   347	  
4	   322	   340	   344	  
5	   314	   326	   331	  
6	   317	   312	   	  
7	   323	   	   	  
8	   313	   	   	  
Average	  weight	  
change	  (g/day)	  
-­‐4.62	   -­‐8.83	   -­‐5.20	  
Table	  2.	  Shows	  the	  weight	  measured	  everyday	  for	  every	  animal	  in	  trial	  1	  (solid	  diet)	  	  
until	  termination.	  Rat	  1	  died	  during	  surgery.	  
	  
	  
	  
Trial	  2	  	  
Another 4 animals were operated on in trial 2. Animals in trial 2 were fed a gel-based 
diet (described in the method section). This time all of the animals survived surgery, 
but rat 1 had to be terminated 4 days after surgery to do respiratory complications. Rat 
1 presented with rhonchi and had lost 17% of his bodyweight in 4 days. Weight losses 
were seen in all animals in trial 2 but the weight loss was less rapid compared to trial 
1. The animal with the greatest weight loss lost on average 3.72g/day compared to 
8.33g/day in trial 1. All animals in trial 2 were terminated after 11 days since they 
showed no sign of gaining weight. After termination successful vagotomy was 
determined in all of the remaining 3 animals. The three animals that survived until the 
end of the experiment showed no other post-operative complications except weight 
loss. 
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Day	   Rat	  1	  (g)	   Rat	  2	  (g)	   Rat	  3	  (g)	   Rat	  4	  (g)	  
1	   283	   285	   299	   284	  
2	   270	   276	   303	   274	  
3	   249	   266	   290	   265	  
4	   236	   255	   275	   258	  
5	   -­‐	   245	   269	   260	  
6	   	   249	   268	   263	  
7	   	   253	   269	   259	  
8	   	   256	   265	   260	  
9	   	   259	   263	   261	  
10	   	   266	   259	   262	  
11	   	   269	   258	   263	  
Average	  weight	  
change	  (g/day)	  
	   -­‐1.45	   -­‐3.72	   -­‐1.90	  
Table	  3.	  Shows	  the	  weight	  measured	  everyday	  for	  every	  animal	  in	  trial	  2	  (gel	  diet)	  until	  
termination.	  Rat	  1	  had	  to	  be	  terminated	  day	  4	  do	  to	  respiratory	  complications.	  
	  
	  
	  
	  
Trial	  3	  
 
In trial 3 malfunction of the heat pad lead to serious complications during surgery. 
Two of the animals died during surgery while two suffered from burn injuries. These 
two rats were treated with zinc-paste and anti-analgesic but had to be terminated after 
10 days due to steady weight loss. Animals in trial 3 were fed a liquid diet. A big 
difference in the speed of weight loss was seen between the two surviving animals, 
where one lost 7.5 g/day compared to 2.6g/day. After termination none of the animals 
were judged to have successful vagotomies. Due to the severe complications during 
surgery, results from trial 3 are determined to be unreliable. Therefore we did another 
try with liquid diet in trial 4. 
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Day	   Rat	  1	  (g)	   Rat	  4	  (g)	  
1	   346	   335	  
2	   350	   336	  
3	   332	   312	  
4	   323	   303	  
5	   319	   297	  
6	   315	   289	  
7	   319	   290	  
8	   326	   290	  
9	   323	   278	  
10	   320	   260	  
Average	  weight	  
change	  (g/day)	  
-­‐2.60	   -­‐7.50	  
Table	  4.	  Shows	  the	  weight	  measured	  everyday	  for	  every	  animal	  in	  trial	  3	  (liquid	  diet)	  
	  until	  termination.	  Rat	  2	  and	  3	  died	  during	  surgery.	  
	  
	  
Trial	  4	  
 
As mentioned above another try with liquid diet was made in trial 4. This time the 
heat pad was also carefully controlled to prevent any burn injuries. Unfortunately, the 
first animal died during surgery due to damage inflicted on the diaphragm. An 
accidental cut was made in the diaphragm resulting in cardiac arrest. After this a 
different surgical approach was taken as described in the method above. Using this 
method all of the three remaining animals survived surgery. We decided to perform a 
sham-operation on the last animal (Rat 4). Unfortunately, this animal had to be 
terminated the day after surgery since it had chewed through its sutures and ruptured 
the mid-line incision. In order to prevent this from happening to our last two animals, 
we decided to secure their wounds with wound-clips. These two animals started to 
show a positive weight change after 5 days post-surgery and kept on gaining weight 
throughout the whole experiment. Thus both animals reached the goal of surviving 3 
weeks post-surgery and had a final bodyweight that exceeded their weight pre-
surgery, gaining 10.1% and 6.9% of their bodyweight. After termination, rat 3 was 
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determined to have a successful vagotomy while rat 2 was unsuccessful. Thus trial 4 
resulted in 1 animal achieving a stable weight gain with a successful vagotomy. 	  
Day	   Rat	  2	  (g)	   Rat	  3	  (g)	  
1	   297	   290	  
2	   276	   276	  
3	   267	   269	  
4	   264	   260	  
5	   265	   267	  
6	   264	   274	  
7	   264	   272	  
8	   273	   271	  
9	   276	   275	  
10	   277	   279	  
12	   278	   277	  
13	   279	   274	  
14	   281	   290	  
15	   293	   298	  
16	   291	   284	  
17	   300	   291	  
18	   310	   300	  
19	   318	   308	  
20	   327	   315	  
Average	  weight	  
change	  (g/day)	  
+1.50	   +1.25	  
Table	  5.	  Shows	  the	  weight	  measured	  everyday	  for	  every	  animal	  in	  trial	  4	  (liquid	  diet)	  until	  
termination.	  Rat	  1	  died	  during	  surgery	  and	  Rat	  4	  had	  to	  be	  terminated	  the	  day	  after	  operation	  due	  
to	  it	  eating	  through	  its	  sutures.	  
	  
	  
	  
	  
	  
Animal	   Weight	  of	  
ventricle	  (g)	  
Bodyweight	  (g)	  
at	  termination	  
Ventricle:	  
bodyweight	  ratio	  
Successful	  
Vagotomy	  
(ratio	  >	  0.020)	  
1:2	   13	   301	   0.043	   Yes	  
1:3	   4	   304	   0.013	   No	  
1:4	   7	   328	   0.021	   Yes	  
2:2	   8	   272	   0.029	   Yes	  
2:3	   14	   260	   0.054	   Yes	  
2:4	   6	   263	   0.023	   Yes	  
3:1	   4	   319	   0.013	   No	  
3:4	   5	   260	   0.019	   No	  
4:2	   6	   307	   0.020	   No	  
4:3	  	   16	   291	   0.055	   Yes	  
Table	  6.	  Shows	  which	  animals	  (1:1	  =	  Trial	  1:	  Rat	  1)	  were	  successfully	  vagotomized.	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Fig	  4.	  Shows	  that	  40%	  of	  all	  animals	  were	  successfully	  vagotomized.	  	  	  	  	  	  	  	  
	  
Fig	  5.	  Shows	  the	  average	  change	  in	  weight	  for	  every	  animal	  across	  the	  4	  trials	  (T1	  =	  solid	  food,	  T2	  =	  
gel	  food,	  T3	  =	  liquid	  diet,	  T4	  =	  liquid	  diet).	  
Death	  33%	  
Succesfull	  vagotomy	  40%	  
Unsuccesfull	  vagotomy	  27%	  
-­‐10	  -­‐8	  
-­‐6	  -­‐4	  
-­‐2	  0	  
2	  4	  
T1	   T2	   T3	   T4	  
g/
da
y	  
Average	  weight	  change	  (animal)	  
Rat	  1	  Rat	  2	  Rat	  3	  Rat	  4	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Fig	  6.	  Shows	  the	  average	  change	  of	  weight	  in	  the	  animals	  for	  the	  respective	  trial	  (T1	  =	  solid	  food,	  T2	  
=	  gel	  food,	  T3	  =	  liquid	  diet,	  T4	  =	  liquid	  diet).	  This	  shows	  that	  animals	  on	  solid	  food	  had	  the	  most	  
rapid	  weight	  loss	  while	  animals	  on	  liquid	  diet	  it	  trial	  4	  were	  the	  only	  ones	  with	  a	  weight	  gain.	  	  	  	  	  	  	  
	  
Fig	  7.	  Shows	  the	  difference	  in	  the	  average	  weight	  change	  between	  animals	  with	  successful	  vagotomy	  
compared	  to	  unsuccessful	  vagotomy.	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  vagotomy	  
Comparing	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Discussion	  
 
From our results we can see that out of the 16 animals that underwent surgery only 1 
animal managed to achieve a stable weight gain with a successful gastric vagotomy. 
A majority of the animals did survive the surgical procedure and most of these also 
had a successful vagotomy. It was in the post-surgical phase that we faced the biggest 
challenge with trying to maintain the weight of the operated animals. The best results 
to do so were obtained with the liquid diet in trial 4. This diet was also used in trial 3 
without any sign of weight gain, but we think that this is due to the burn damage that 
was inflicted on the rats. 
 
The fact that subdiaphragmatic vagotomy causes weight loss in the rat has previously 
been described in several studies. It has been shown that post-operative syndromes 
after vagotomy include hypophagia, hypodipsia and loss of body weight if rats are 
remained on a solid diet. These symptoms can be counteracted if rats are instead 
maintained on a liquid diet after surgery [21]. This is in line with the results from our 
study where the only animals showing weight gain were the ones fed with a liquid 
diet. A weight loss following abdominal vagotomy has also been observed in humans, 
where a loss of 10-30% of the preoperative weight has been reported [22]. This 
weight loss is believed to be caused by the loss of both efferent and afferent function 
of the abdominal vagus nerve after vagotomy. It is known that the vagus nerve is 
involved in the motility of the ventricle where it controls the gastric contractions and 
the following gastric emptying. Thus, manipulating this nerve control can cause 
gastroparesis resulting in gastric retention of solid food. To avoid this, pyloroplasty 
was often performed in combination with abdominal vagotomy in order to create 
drainage of the gastric contents [22]. Unfortunately, it has also been documented that 
	   29	  
pyloroplasty can cause complications such as dumping syndrome where food is 
passed to quickly to the small intestine, exacerbating weight-loss [23].  Also previous 
experiences show that it is difficult to successfully perform pyloroplasty in the rat 
without leakage and subsequent abdominal infections. Because of this we wanted to 
avoid performing pyloroplasty on the animals in our study. Instead by using a liquid 
diet we managed to achieve a weight gain without a pyloroplasty and thus we think 
that this drainage procedure can be avoided as long as we keep the animals on this 
specific diet. Furthermore, some studies indicate that the weight loss after vagotomy 
is not primarily caused by gastric retention, but by decreased food intake [24]. Since 
the vagus nerve is predominantly an afferent nerve it has been shown that it mediates 
sensory information from the gut to the brain using both mechanoreceptors and 
chemical signaling, such as via hormones like cholecystokinin (CCK-8) [25].  It 
seems like ligation of the afferent vagus nerves abolishes this sensory information 
resulting in decreased sensation of hunger and food intake [26]. Knowing that 
vagotomized rats present with a decreased food intake, we decided to prevent further 
weight loss by choosing a liquid diet with a high calorie content. Thus even if the 
animals drank less after surgery compared with intake pre-surgery, they would 
hopefully still have a calorie intake sufficient to produce weight gain. This strategy 
seemed to work since both animals in trial 4 showed a weight gain, where one of them 
also had a successful vagotomy. Having said this, it is also important to highlight the 
fact that weight loss were seen both in animals with and without successful 
vagotomies (see fig.7). There may be several reasons for this occurrence. Only 
animals with complete dissection of all fibers of the vagus nerve are judged to be 
successfully vagotomized with the verification method we used (with 95%-
confidence). Therefore animals judged to have unsuccessful vagotomies could have 
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had parts of the vagus nerve fibers dissected, enough to present with a weight loss but 
not enough for a successful vagotomy. Furthermore, although care was taken to not 
inflict damage to the esophagus during surgery, the closeness of the gastric vagus 
nerve branches puts the esophagus at risk. Thus if any damages to the esophagus were 
made these could have caused dysphagia in the animal, resulting in a weight loss. 
However, liquid diet should facilitate food intake even though dysphagia is present, 
which is in line with the fact that liquid diet was the only diet that produced a post-
operative weight gain in our study. Other possible reasons for weight loss in non-
vagotomized rats could include the ordinary conditions after any surgery such as 
nausea and pain. Unfortunately, our sham-rat in trial 4 did not survive; otherwise we 
would have had more information about to which extent nausea and pain effects food 
intake. What can be said is that we had careful daily observation of the operated 
animals and saw no signs of vomiting in the cage. Pain is on the other hand a very 
possible cause to decreased food intake. It can therefor be discussed if our pain-
management was sufficient or if we need a more continuous administration 
alternatively stronger drugs. Although, since we were using Carprofen, a NSAID, care 
must be taken to not prolong administration more than necessary in order to prevent 
gastric ulcers in an already sensitive ventricle after the vagotomy. The other option is 
to use morphine, but in our case this is not appropriate mainly because of two reasons. 
Firstly it is known that morphine causes decreased bowel motility, which results in 
obstipation, which in turn contributes to the retention of food that we want to avoid. 
Secondly, since our aim is to use these vagotomized animals in a future ethanol-
consumption study we can´t take any risks of having an analgesic like morphine, 
which effects central opioid receptors.  
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Another important point to address is the accuracy of the verification method used to 
determine successful vagotomy. In past studies several different methods have been 
presented to verify the success of gastric vagotomy in the rat. One of the more widely 
used verification methods is the anatomic verification of vagotomy. When using this 
method sutures must be placed where the two vagus nerve branches are ligated during 
surgery. After termination of the animals these sutures are again located using a 
microscope. If no nerve fibers are seen to connect the two nerve ends the vagotomy is 
judged to be complete [27].  Although this anatomical verification is frequently used 
in studies we decided to use another method measuring post-fast stomach to 
bodyweight ratio. The reason for this is that the stomach-bodyweight ratio method is 
much more practical to use and has less technical challenges compared to the 
anatomic verification method. The post-fast method has also been shown to have a 
great accuracy to determine successful vagotomy in a study where success of 
vagotomy was judged with both post-fast stomach-bodyweight ratio and 
electrophysiological verification, which is the most reliable verification method. This 
study showed that electric transmission in the vagus nerve was impaired in rats with a 
stomach-bodyweight ratio exceeding 0.020 and concluded that this ratio can be used 
with a 95%-confident to determine successful vagotomy [20]. With this information 
we find the post-fast method used in our study to be an adequate verification method 
at this stage of the study where we are still developing the procedure. Using the post-
fast method, 40% of the operated animals in our study were judged to be successfully 
vagotomized. Surely a greater success rate must be achieved before we can feel 
confident enough to use this present method in a future drinking study of a larger 
scale. We believe that in order to increase the success rate of the operation, simply 
more surgical practice is needed by the operator. Also the new surgical approach, 
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described in the method above, were we temporarily put the intestines extra-
abdominally to gain easier access to the nerves, may result in more successful 
vagotomies. We feel that this approach provides less risk to damage vital organs such 
as the liver and diaphragm and also gives better visualization of the vagus nerve 
branches.  However more trials must be conducted using this method in order to 
evaluate this theory. 
 
 As mentioned above vagotomy induces difficulties in the digestive system, which 
results in decreased food intake and weight loss. Since our aim is to later use these 
vagotomized rats in a voluntary alcohol consumption study measuring ethanol intake 
after intermittent administration of nicotine, we must assure that these digestive 
complications do not affect ethanol intake. Ethanol is known for it’s high calorie 
content and does in that aspect share similarities with food. This may produce the 
same behavioral effect to ethanol as to food in the vagotomized rat, in other words a 
decreased intake. We therefore believe that we must achieve a steady post-surgical 
food intake in the rat, preferably comparable to the intake of sham-rats, before 
introducing the animals to ethanol. This will allow the influence of calorie-dependent 
ethanol intake to be minimal since animals already show a positive behavior to food 
intake with a subsequent weight gain. We are hopeful that the liquid diet used in 
experiment 4 will allow us to achieve this behavior of steady food intake in the 
vagotomized rat since it shows promising results regarding weight gain. 
Unfortunately, we lost our only sham-operated rat in experiment 4. Even though data 
from only on sham-rat is not enough, it would still have given us important direction 
about whether this diet is able to produce the same weight gain in both rats who have 
underwent manipulation of the vagus nerve and those who haven´t. 
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In summary, we have managed to describe a method for gastric vagotomy that 
includes a regimen for anesthesia, a new surgical approach, and a post-surgical 
management plan and verification method. It is clear that the post-surgical weight loss 
is the greatest challenge when performing gastric vagotomy, but that the weight of the 
animals can be successfully maintained using a liquid diet with high calorie content. 
Surely more practice is needed to increase the accuracy rate of successful vagotomies, 
but we believe that we have identified the fundamental of a method that can be used 
in future drinking studies. Our plan is to proceed with more trials in order to further 
develop the skills for the surgical procedure, evaluate pain-management and diets and 
gain more data about the behavior of vagotomized rats compared to sham-operated 
rats. When we have achieved the success rate we want, we hope to use this method to 
further investigate if manipulation of the vagus nerve truly affects ethanol intake in 
the nicotine pre-treated rat during an ethanol-consumption study.	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Populärvetenskaplig	  sammanfattning	  	  
Nikotin-­‐inducerad	  eskalation	  av	  etanolintag	  –	  en	  effekt	  som	  förmedlas	  via	  
vagusnerven?	  	  
Alkoholberoende och missbruk är en kronisk återfallssjukdom med vittgående 
medicinska och sociala konsekvenser. Nyligen publicerades en artikel (Lancet (2012) 
380: 2224–60) som fann att alkohol är den tredje största bidragande orsaken till för 
tidig död i ett världsperspektiv (efter högt blodtryck och tobaksrökning). Om vi ökar 
förståelsen för hur man blir beroende av alkohol kan vi försöka utveckla nya 
läkemedel mot sjukdomen och på så sätt minska ett enormt lidande.  
 
Denna studie fokuserar sig på det nära samband som har visat sig existera mellan 
alkoholberoende och nikotinintag. Ungefär 70 % av alla alkoholister är rökare och det 
är tio gånger vanligare att en rökare är alkoholist än en icke-rökare.  I en djurmodell 
har man tidigare visat att nikotinbehandling till råtta driver upp dess frivilliga 
alkoholkonsumtion. Vi har även funnit att ökningen av alkoholintaget inte primärt 
beror på en central (i hjärnan) mekanism utan inkluderar sannolikt en perifer (ute i 
kroppen) funktion. Vi tror alltså att nikotin påverkar nikotinreceptorer ute i kroppen 
och att det sedan sker någon koppling mellan de perifera receptorerna och de centrala 
vilket får en effekt på alkoholintaget. Vi har skäl att tro att en sådan koppling kan ske 
via en ökad autonomisk signaltransmission och förmedlas via en nerv som heter 
Vagus. Vår hypotes är därmed att om man bryter vagusnervens influens kommer 
nikotinbehandling inte att driva upp det frivilliga alkoholintaget hos råtta. Syftet med 
denna studie var därför att utveckla en kirurgisk metod för att klippa av delar av 
vagusnerven hos råtta och på så sätt bryta dess signalöverföring. Om vi lyckas med 
detta kan vi använda metoden i framtida alkoholkonsumtionsstudier för att närmare 
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undersöka vilken roll vagusnerven spelar i kopplingen mellan nikotin och 
alkoholintag. 
 
Totalt opererades 16 råttor under denna studiens gång och vi lyckades klippa av 
vagusnerven hos 6 av dessa. Dock möttes vi av en stor utmaning i form av snabb 
viktnedgång hos djuren efter operation. Vi behövde därför använda oss av olika dieter 
för att motverka viktnedgången, och till slut fann vi att en kaloririk näringsdryck var 
det bästa alternativet för att stabilisera vikten. Av de 16 djur som deltog i studien var 
det bara 1 djur som genomgick en lyckad manipulering av nerven samt kunde 
upprätthålla en stabil viktuppgång. I denna studie lyckades vi beskriva en metod för 
att klippa av en del av vagusnerven, men det krävs fortfarande mer kirurgisk träning 
för att uppnå den träffsäkerhet som krävs för att använda sig av metoden i en större 
alkoholkonsumtionsstudie. Vår slutsats är att med mer träning och en post-operativ 
diet bestående av kaloririk näringsdryck hoppas vi att på att kunna uppnå en tillräcklig 
bra metod för manipulering av vagusnerven som kan användas i senare 
alkoholkonsumtionsstudier.   
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